These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28338340)

  • 21. [SERUM CYTOKINE CONCENTRATIONS ASSOCIATION WITH THE SEVERITY OF SYMPTOMS IN MAJOR DEPRESSION].
    Madi Y; Yogev A; Bar-Gad M; Amital H; Barak V; Amital D
    Harefuah; 2017 Dec; 156(12):753-756. PubMed ID: 29292611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts.
    Sowa-Kućma M; Styczeń K; Siwek M; Misztak P; Nowak RJ; Dudek D; Rybakowski JK; Nowak G; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():372-383. PubMed ID: 28867391
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder.
    Sasayama D; Hattori K; Wakabayashi C; Teraishi T; Hori H; Ota M; Yoshida S; Arima K; Higuchi T; Amano N; Kunugi H
    J Psychiatr Res; 2013 Mar; 47(3):401-6. PubMed ID: 23290488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients.
    Diniz BS; Teixeira AL; Talib L; Gattaz WF; Forlenza OV
    Am J Geriatr Psychiatry; 2010 Feb; 18(2):172-6. PubMed ID: 20104073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated triglyceride levels are associated with cognitive impairments among patients with major depressive disorder.
    Shao TN; Yin GZ; Yin XL; Wu JQ; Du XD; Zhu HL; Liu JH; Wang XQ; Xu DW; Tang WJ; Hui L
    Compr Psychiatry; 2017 May; 75():103-109. PubMed ID: 28342378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma levels of brain-derived neurotrophic factor and interleukin-6 in patients with dysthymic disorder: comparison with age- and sex-matched major depressed patients and healthy controls.
    Yoshimura R; Umene-Nakano W; Hoshuyama T; Ikenouchi-Sugita A; Hori H; Katsuki A; Hayashi K; Atake K; Nakamura J
    Hum Psychopharmacol; 2010 Nov; 25(7-8):566-9. PubMed ID: 21312291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum levels of vitamin E forms and risk of cognitive impairment in a Finnish cohort of older adults.
    Mangialasche F; Solomon A; Kåreholt I; Hooshmand B; Cecchetti R; Fratiglioni L; Soininen H; Laatikainen T; Mecocci P; Kivipelto M
    Exp Gerontol; 2013 Dec; 48(12):1428-35. PubMed ID: 24113154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Cross-sectional and Longitudinal Associations Between IL-6, IL-10, and TNFα and Cognitive Outcomes in the Mayo Clinic Study of Aging.
    Wennberg AMV; Hagen CE; Machulda MM; Knopman DS; Petersen RC; Mielke MM
    J Gerontol A Biol Sci Med Sci; 2019 Jul; 74(8):1289-1295. PubMed ID: 30256904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RELATIONSHIP BETWEEN THE CORTICAL THICKNESS AND SERUM CORTISOL LEVELS IN DRUG-NAÏVE, FIRST-EPISODE PATIENTS WITH MAJOR DEPRESSIVE DISORDER: A SURFACE-BASED MORPHOMETRIC STUDY.
    Liu X; Kakeda S; Watanabe K; Yoshimura R; Abe O; Ide S; Hayashi K; Katsuki A; Umeno-Nakano W; Watanabe R; Ueda I; Moriya J; Nakamura J; Korogi Y
    Depress Anxiety; 2015 Sep; 32(9):702-8. PubMed ID: 26290363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced plasma Fetuin-A is a promising biomarker of depression in the elderly.
    Fanelli G; Benedetti F; Wang SM; Lee SJ; Jun TY; Masand PS; Patkar AA; Han C; Serretti A; Pae CU; Fabbri C
    Eur Arch Psychiatry Clin Neurosci; 2020 Oct; 270(7):901-910. PubMed ID: 31863164
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression.
    Diniz BS; Teixeira AL; Talib LL; Mendonça VA; Gattaz WF; Forlenza OV
    J Psychiatr Res; 2010 Oct; 44(14):917-20. PubMed ID: 20338581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase in interleukin-1beta in late-life depression.
    Thomas AJ; Davis S; Morris C; Jackson E; Harrison R; O'Brien JT
    Am J Psychiatry; 2005 Jan; 162(1):175-7. PubMed ID: 15625217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum tumour necrosis factor-α and interleukin-6 levels in Alzheimer's disease and mild cognitive impairment.
    Kim YS; Lee KJ; Kim H
    Psychogeriatrics; 2017 Jul; 17(4):224-230. PubMed ID: 28130814
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Discrepancy Between Subjective Memory Complaints and Objective Memory Deficits in Elderly Patients with Depression Compared to Mild Cognitive Impairment].
    Duman B; Özel Kızıl ET; Baran Z; Kırıcı S; Turan E
    Turk Psikiyatri Derg; 2016; 27(1):1-7. PubMed ID: 27369679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of interleukin-10 levels with age of onset and duration of illness in patients with major depressive disorder.
    Gazal M; Jansen K; Souza LD; Oses JP; Magalhães PV; Pinheiro R; Ghisleni G; Quevedo L; Kaster MP; Kapczinski F; da Silva RA
    Braz J Psychiatry; 2015; 37(4):296-302. PubMed ID: 26421934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between serum brain-derived neurotrophic factor and plasma interleukin-6 in major depressive disorder with melancholic features.
    Patas K; Penninx BW; Bus BA; Vogelzangs N; Molendijk ML; Elzinga BM; Bosker FJ; Oude Voshaar RC
    Brain Behav Immun; 2014 Feb; 36():71-9. PubMed ID: 24140302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression.
    Dhabhar FS; Burke HM; Epel ES; Mellon SH; Rosser R; Reus VI; Wolkowitz OM
    J Psychiatr Res; 2009 Jul; 43(11):962-9. PubMed ID: 19552919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inflammatory cytokines and functional impairment in drug-free subjects with mood disorder.
    Wiener CD; Moreira FP; Cardoso TA; Mondin TC; da Silva Magalhães PV; Kapczinski F; de Mattos Souza LD; da Silva RA; Oses JP; Jansen K
    J Neuroimmunol; 2017 Jun; 307():33-36. PubMed ID: 28495135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Both Serum Brain-Derived Neurotrophic Factor and Interleukin-6 Levels Are Not Associated with Therapeutic Response to Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder.
    Kagawa S; Mihara K; Suzuki T; Nagai G; Nakamura A; Nemoto K; Kondo T
    Neuropsychobiology; 2017; 75(3):145-150. PubMed ID: 29332095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between increased circulating endothelial progenitor cell levels and anxiety/depressive severity, cognitive deficit and function disability among patients with major depressive disorder.
    Liou YJ; Chen MH; Hsu JW; Huang KL; Huang PH; Bai YM
    Sci Rep; 2021 Sep; 11(1):18221. PubMed ID: 34521977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.